Skip to content
healthcare.dev

Cefpodoxime Proxetil

NDC 65862-141, Cefpodoxime Proxetil, granule, for suspension, from Aurobindo Pharma Limited.

Product NDC
65862-141
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
GRANULE, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA065409
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CEFPODOXIME PROXETIL100 mg/5mL

Pharmacologic classes

Cephalosporin Antibacterial [EPC]; Cephalosporins [CS]

Package NDCNDC-11Package
65862-141-01658620141011 BOTTLE in 1 CARTON (65862-141-01) / 100 mL in 1 BOTTLE
65862-141-50658620141501 BOTTLE in 1 CARTON (65862-141-50) / 50 mL in 1 BOTTLE
65862-141-75658620141751 BOTTLE in 1 CARTON (65862-141-75) / 75 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/63777889-d306-4fc3-88da-b24859040ef4

Use it

Look up 65862-141 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-141. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.